NSE: MEDANTA | BSE: 543654

Expensive Star

Download real time

1362.90 13.50 (1.00%)

36.78% Gain from 52W Low

442.1K NSE+BSE Volume

NSE 13 Oct, 2025 3:31 PM (IST)

36,633.4

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Global Health Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for MEDANTA, BSE:543654 Global Health Ltd.

Search Inside the pdf :

Global Health Ltd.

11 Aug 2025

1362.90

1.00%

Result Update:Global Health

Buy: Global Health Ltd.

Target

Axis Direct

We maintain a BUY rating on Medanta, supported by the expected recovery from temporary business disruptions, improvement in ARPOB, and incremental bed capacity addition, including the Noida hospital, which is likely to be operational by the end of H1FY26E.

Global Health Ltd. has an average target of 1451.67 from 3 brokers.

Global Health Ltd.

10 Aug 2025

1362.90

1.00%

Performance above est.; record revenue for the quarter

Buy: Global Health Ltd.

Target

Motilal Oswal

Global Health (Medanta) delivered better-than-expected 1QFY26. Improved performance in mature as well as developing hospitals led to a 7%/6%/11% beat on our sales/EBITDA/PAT estimates for the quarter.

Global Health Ltd. is trading above all available SMAs

Global Health Ltd.

17 May 2025

1362.90

1.00%

Q4FY25: In-line performance

Sell: Global Health Ltd.

Emkay

Global Health (Medanta)’s Q4FY25 print was in line with street/our estimates. The Developing portfolio continued its healthy trajectory, as OBD grew 36% YoY (favorable base) while ARPOBs fell 7% on higher contribution of schemebased patients in both—Lucknow and Patna units.

Number of FII/FPI investors increased from 208 to 215 in Jun 2025 qtr.

Global Health Ltd.

24 Mar 2025

1362.90

1.00%

Axis Punch:Global Health

Buy: Global Health Ltd.

Target

Axis Direct

We recommend a BUY on the stock with a target price of Rs 1,390/share, implying an upside of 10% from the CMP

Number of FII/FPI investors increased from 208 to 215 in Jun 2025 qtr.

Global Health Ltd.

06 Feb 2025

1362.90

1.00%

Result Update:Global Health

Buy: Global Health Ltd.

Target

Axis Direct

We maintain a BUY rating on Medanta

Global Health Ltd. has gained 33.00% in the last 1 Year

Global Health Ltd.

30 Nov 2024

1362.90

1.00%

Pick of the Week:2 December 2024

Buy: Global Health Ltd.

Axis Direct

We recommend a BUY rating on the stock with a target price of Rs 1200/share, implying an upside of 11% from the CMP.

Global Health Ltd. has an average target of 1451.67 from 3 brokers.

Global Health Ltd.

18 Nov 2024

1362.90

1.00%

Result Update:Global Health

Buy: Global Health Ltd.

Target

Axis Direct

The target price is set at Rs 1,200/share, representing an upside potential of 12% from the CMP. This valuation is based on a multiple of 25x EV/EBITDA for FY26E.

Number of FII/FPI investors increased from 208 to 215 in Jun 2025 qtr.

Global Health Ltd.

06 Sep 2024

1362.90

1.00%

Witnessing recovery in developing hospitals

Buy: Global Health Ltd.

Target

Motilal Oswal

With a strong presence in the north/central region of India, MEDANTA has ~3,440 bed capacity as of 1QFY25. It is ramping up its capacity/capabilities in these regions, especially in Lucknow/Patna/Noida, with plans to add ~500 beds.